Jeff Johnson
Stock Analyst at Baird
(4.69)
# 192
Out of 4,915 analysts
145
Total ratings
60.2%
Success rate
30.92%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Maintains: Neutral | $15 → $17 | $17.03 | -0.15% | 2 | Jul 30, 2025 | |
| HSIC Henry Schein | Downgrades: Neutral | $82 → $72 | $68.70 | +4.80% | 10 | Jul 14, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $107 → $97 | $71.66 | +35.36% | 17 | May 30, 2025 | |
| NVST Envista Holdings | Upgrades: Outperform | $21 → $23 | $19.46 | +18.19% | 10 | May 27, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $130 → $115 | $92.78 | +23.95% | 14 | May 6, 2025 | |
| DXCM DexCom | Maintains: Outperform | $115 → $105 | $84.23 | +24.66% | 14 | May 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $33 → $24 | $16.06 | +49.44% | 16 | May 1, 2025 | |
| ALC Alcon | Maintains: Outperform | $104 → $108 | $88.36 | +22.23% | 9 | Feb 27, 2025 | |
| SYK Stryker | Maintains: Outperform | $378 → $405 | $400.68 | +1.08% | 11 | Oct 30, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $325 → $276 | $140.73 | +96.12% | 18 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $180 → $238 | $292.79 | -18.71% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $70 | $26.62 | +162.96% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $53 → $61 | $13.71 | +344.93% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $67 | $14.85 | +351.33% | 6 | Feb 18, 2022 |
Beta Bionics
Jul 30, 2025
Maintains: Neutral
Price Target: $15 → $17
Current: $17.03
Upside: -0.15%
Henry Schein
Jul 14, 2025
Downgrades: Neutral
Price Target: $82 → $72
Current: $68.70
Upside: +4.80%
The Cooper Companies
May 30, 2025
Maintains: Outperform
Price Target: $107 → $97
Current: $71.66
Upside: +35.36%
Envista Holdings
May 27, 2025
Upgrades: Outperform
Price Target: $21 → $23
Current: $19.46
Upside: +18.19%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $130 → $115
Current: $92.78
Upside: +23.95%
DexCom
May 2, 2025
Maintains: Outperform
Price Target: $115 → $105
Current: $84.23
Upside: +24.66%
Tandem Diabetes Care
May 1, 2025
Maintains: Neutral
Price Target: $33 → $24
Current: $16.06
Upside: +49.44%
Alcon
Feb 27, 2025
Maintains: Outperform
Price Target: $104 → $108
Current: $88.36
Upside: +22.23%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $378 → $405
Current: $400.68
Upside: +1.08%
Align Technology
Oct 24, 2024
Maintains: Outperform
Price Target: $325 → $276
Current: $140.73
Upside: +96.12%
Dec 21, 2023
Upgrades: Outperform
Price Target: $180 → $238
Current: $292.79
Upside: -18.71%
Aug 4, 2023
Maintains: Outperform
Price Target: $67 → $70
Current: $26.62
Upside: +162.96%
Jul 28, 2023
Maintains: Outperform
Price Target: $53 → $61
Current: $13.71
Upside: +344.93%
Feb 18, 2022
Maintains: Outperform
Price Target: $78 → $67
Current: $14.85
Upside: +351.33%